“Haemophilus influenzae Type b/Polyribosylribitol Phosphate-Tetanus (Hib/PRP-T) Vaccine Safety, Phase I Study”, IJIHS, vol. 3, no. 2, pp. 55–59, Sep. 2015, doi: 10.15850/ijihs.v3n2.584.